|
|
||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 273, Issue 2 333-G341, Copyright © 1997 by American Physiological Society
ARTICLES |
I. Castagliuolo, C. P. Kelly, B. S. Qiu, S. T. Nikulasson, J. T. LaMont and C. Pothoulakis
Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston 02215, USA.
Interleukin-11 (IL-11) is a stromal cell-derived cytokine with several biological activities against hematopoietic cells. Recent results indicated that IL-11 reduced mucosal damage in animal models of colitis. This study aimed to explore the action of recombinant human IL-11 (rhIL-11) on the intestinal effects of Clostridium difficile toxin A, an inflammatory enterotoxin, and cholera toxin, a noninflammatory enterotoxin in rat ileum. We administered rhIL-11 subcutaneously to rats before injection of toxin A into ileal loops and measured fluid secretion, epithelial permeability to mannitol, histopathological damage, and release of rat mast cell protease II (RMCP II) from intestinal mast cells and of tumor necrosis factor-alpha (TNF-alpha) and macrophage inflammatory protein-2 (MIP-2) from lamina propria macrophages. rhIL-11 (50-1,000 micrograms/kg) inhibited toxin A but not cholera toxin-mediated secretion and permeability in a dose-dependent fashion and reduced toxin A-induced epithelial cell damage. Rats treated with rhIL-11 also showed reduced RMCP II, TNF-alpha, and MIP-2 release in response to toxin A. Exposure of rat peripheral monocytes in vitro to rhIL-11 (1 microgram/ml) inhibited lipopolysaccharide and toxin A-mediated increases in TNF-alpha mRNA and protein levels. We conclude that rhIL-11 blocks the intestinal effects of C. difficile toxin A, possibly by inhibiting release of inflammatory mediators from mucosal mast cells and intestinal macrophages.
This article has been cited by other articles:
![]() |
K. M. Naugler, K. A. Baer, and M. J. Ropeleski Interleukin-11 antagonizes Fas ligand-mediated apoptosis in IEC-18 intestinal epithelial crypt cells: role of MEK and Akt-dependent signaling Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G728 - G737. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Greenwood-Van Meerveld, K. Venkova, and J. C. Keith Jr. Recombinant Human Interleukin-11 Restores Smooth Muscle Function in the Jejunum and Colon of Human Leukocyte Antigen-B27 Rats with Intestinal Inflammation J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 58 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Castagliuolo, K. Karalis, L. Valenick, A. Pasha, S. Nikulasson, M. Wlk, and C. Pothoulakis Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in rats Am J Physiol Gastrointest Liver Physiol, April 1, 2001; 280(4): G539 - G545. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Depoortere, T. Thijs, G. Van Assche, J. C. Keith Jr., and T. L. Peeters Dose-Dependent Effects of Recombinant Human Interleukin-11 on Contractile Properties in Rabbit 2,4,6-Trinitrobenzene Sulfonic Acid Colitis J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 983 - 990. [Abstract] [Full Text] |
||||
![]() |
I. Castagliuolo, M. F. Riegler, L. Valenick, J. T. LaMont, and C. Pothoulakis Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa Infect. Immun., January 1, 1999; 67(1): 302 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Castagliuolo, A. C. Keates, C. C. Wang, A. Pasha, L. Valenick, C. P. Kelly, S. T. Nikulasson, J. T. LaMont, and C. Pothoulakis Clostridium difficile Toxin A Stimulates Macrophage- Inflammatory Protein-2 Production in Rat Intestinal Epithelial Cells J. Immunol., June 15, 1998; 160(12): 6039 - 6045. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |